Clinical Trial Update: Study of CIDP Patients During IVIG Treatment

View source ↗

Summary

A completed clinical trial examining CIDP patients treated with intravenous immunoglobulin (IVIG).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Aarhus | Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Status: COMPLETED